Shawn Shafer has been working in the genome editing and functional genomics fields for over 20 years. He joined Aldevron as Genome Editing Platform Lead to grow their CRISPR portfolio supporting cellular and genome editing therapies. Prior to Aldevron, he directed MilliporeSigma’s Advanced Genomics business, developing CRISPR, ZFN, RNAi, molecular diagnostic, and functional genomics technologies. Dr. Shafer holds a Ph.D. in Developmental Biology from Washington University in St. Louis and a B.S. in Biology from University of Missouri, St. Louis.